Sign in

CIK 0001175151

  • Non-accelerated filer
  • Smaller reporting company

Cytosorbents Corp

Sign in to watch
Ticker
CTSO
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
980373793
Phone
+1 973-329-8885
Business address
305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Former names
MedaSorb Technologies CORP, GILDER ENTERPRISES INC
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market sale Director sold 10,000 shares at $5.98 ($59,779)
  3. 4 Open-market sale Director sold 10,000 shares at $6.29 ($62,852)
  4. 4 Open-market sale Director sold 13,205 shares at an average $7.33 ($96,781)
  5. 4 Open-market sale Director sold 10,000 shares at $5.78 ($57,782)
  6. 4 Open-market sale Director sold 10,000 shares at $6.29 ($62,883)
  7. 4 Open-market sale Director sold 10,000 shares at $6.30 ($63,000)
  8. 4 Open-market sale Director sold 10,000 shares at $6.32 ($63,247)
  9. 4 Open-market sale Director sold 10,000 shares at $6.08 ($60,823)
  10. 4 Open-market sale Director sold 10,000 shares at $6.00 ($59,996)
  11. 4 Open-market sale Chief Operating Officer sold 4,000 shares at $7.50 ($30,000)
  12. 4 Grant or award Director acquired 55,000 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Grant or award Director acquired 55,000 shares (grant or award)
  15. 4 Grant or award Director acquired 55,000 shares (grant or award)
  16. 4 Grant or award President and CEO acquired 130,000 shares (grant or award)
  17. 4 Grant or award Chief Operating Officer acquired 125,000 shares (grant or award)
  18. 4 Grant or award Chief Medical Officer acquired 30,000 shares (grant or award)
  19. 4 Grant or award Director acquired 55,000 shares (grant or award)
  20. 4 Grant or award Chief Financial Officer acquired 110,000 shares (grant or award)

Page 13 of 20 · 395 filings